VestGen Advisors’s Astera Labs ALAB Stock Holding History

VestGen Advisors’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$355K	Sell	734 -771	-51%	-$205K	0.01%	782
2026 Q1	$308K	Buy	+1,505	New	+$214K	0.01%	828

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

VestGen Advisors's ALAB Position: Q2 2026 in Review

VestGen Advisors reduced its Astera Labs (ALAB) stake by 51% in Q2 2026, selling an estimated $205K and leaving 734 shares worth $355K. The position accounts for 0.01% of the portfolio, ranked #782.

VestGen Advisors first reported a position in ALAB in Q1 2026 and has held it in 2 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

VestGen Advisors held 734 shares of Astera Labs worth $355K as of Q2 2026.
VestGen Advisors sold 771 Astera Labs shares in Q2 2026, an estimated $205K.
Astera Labs made up 0.01% of VestGen Advisors's portfolio in Q2 2026, its #782 holding.
VestGen Advisors first reported a position in Astera Labs in Q1 2026 and has held it in 2 quarters since.
988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.